Literature DB >> 17967589

Effect of pulmonary stenosis on pregnancy outcomes--a case-control study.

Afshan B Hameed1, Thomas Murphy Goodwin, Uri Elkayam.   

Abstract

BACKGROUND: Pulmonary stenosis (PS) accounts for 10% to 12% of congenital heart disease in adults, and the probability of survival to child bearing age is high. The impact of PS on pregnancy has not been extensively studied in the recent era.
METHODS: We evaluate the effect of isolated PS on maternal and fetal outcomes in a case-control study of 17 cases with PS in pregnancy from 1995 to 2006. The control group was matched by age, ethnicity, obstetrical history, and year of delivery. Patients with PS were assessed for maternal New York Heart Association (NYHA) functional class and other maternal complications at baseline and during pregnancy; and the 2 groups were compared for fetal and neonatal outcomes including birth weight, gestational age at delivery, Apgar scores, and placental weight.
RESULTS: A total of 11 patients were in NYHA functional class I and 6 in class II at the time of presentation. All patients remained stable during pregnancy except for two. One of them deteriorated from NYHA functional class I to II, and the other from class II transiently to class III. There were no other maternal complications. In addition, there were no statistically significant differences in fetal/neonatal outcomes between patients and their controls and between patients with mild and severe PS.
CONCLUSIONS: In contrast to mitral and aortic stenosis, PS does not adversely impact maternal or fetal outcomes of pregnancy.

Entities:  

Mesh:

Year:  2007        PMID: 17967589     DOI: 10.1016/j.ahj.2007.07.016

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  9 in total

Review 1.  Role of echocardiography in the assessment and management of adult congenital heart disease in pregnancy.

Authors:  Antonio Vitarelli; Lidia Capotosto
Journal:  Int J Cardiovasc Imaging       Date:  2010-11-17       Impact factor: 2.357

2.  Pregnancy in young women with congenital heart disease: Lesion-specific considerations.

Authors:  Rachel M Wald; Mathew Sermer; Jack M Colman
Journal:  Paediatr Child Health       Date:  2011-05       Impact factor: 2.253

Review 3.  Sex Differences and Similarities in Valvular Heart Disease.

Authors:  Jacqueline T DesJardin; Joanna Chikwe; Rebecca T Hahn; Judy W Hung; Francesca N Delling
Journal:  Circ Res       Date:  2022-02-17       Impact factor: 17.367

Review 4.  Management of Women With Congenital or Inherited Cardiovascular Disease From Pre-Conception Through Pregnancy and Postpartum: JACC Focus Seminar 2/5.

Authors:  Kathryn J Lindley; C Noel Bairey Merz; Anita W Asgar; Natalie A Bello; Sonal Chandra; Melinda B Davis; Mardi Gomberg-Maitland; Martha Gulati; Lisa M Hollier; Eric V Krieger; Ki Park; Candice Silversides; Natasha K Wolfe; Carl J Pepine
Journal:  J Am Coll Cardiol       Date:  2021-04-13       Impact factor: 24.094

Review 5.  Pregnancy complicated by valvular heart disease: an update.

Authors:  Michael Nanna; Kathleen Stergiopoulos
Journal:  J Am Heart Assoc       Date:  2014-06-05       Impact factor: 5.501

6.  Pulmonary Balloon Valvuloplasty during Pregnancy.

Authors:  Mustafa Oylumlu; Kazim Aykent; Hatice Ender Soydinc; Muhammed Oylumlu; Faruk Ertas; Hasan Orhan Ozer; Ibrahim Sari
Journal:  Case Rep Cardiol       Date:  2012-11-11

7.  Anesthetic Management of a Parturient with Severe Pulmonary Restenosis Posted for Cesarean Section.

Authors:  Rajkiran Babubhai Shah; Beena P Butala; Geeta P Parikh
Journal:  Anesth Essays Res       Date:  2017 Apr-Jun

Review 8.  Cardiovascular Imaging in Pregnancy: Valvulopathy, Hypertrophic Cardiomyopathy, and Aortopathy.

Authors:  Haneen Ismail; Andrew J Bradley; Jannet F Lewis
Journal:  Front Cardiovasc Med       Date:  2022-08-03

Review 9.  Echocardiography in Pregnancy: Part 2.

Authors:  Meena Narayanan; Uri Elkayam; Tasneem Z Naqvi
Journal:  Curr Cardiol Rep       Date:  2016-09       Impact factor: 2.931

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.